ALEXION PHARMACEUTICALS, INC. (SYNTIMMUNE, INC.) Overview
Company Headquarters: Massachusetts, US
Founded: 1992
Workforce: ~3,000
Company Working:
Alexion Pharmaceuticals, Inc. (Alexion) is a global biopharmaceutical company focused on the discovery, development, and commercialization of life-changing therapies. The firm offers its products for a wide range of therapies including hematology, neurology, metabolic disorders, and among others. The company provides its well-known brands in the global market namely, Ultomiris, Soliris, Strensiq, and Kanuma. It has a direct and indirect presence in more than 50 countries including Switzerland, the US, UK, Japan, Mexico, Canada, etc. It offers its products to customers such as pharmacies, hospitals, hospital buying groups, and other healthcare providers. The company has a strong presence in Europe, North America, Latin America, and Asia-Pacific.
Strategy
Alexion Pharmaceuticals, Inc. focuses on offering its branded products across the globe. It focuses on the research and development in core therapeutic areas to launch innovative products in the market. Moreover, it focused on expands its rare disease business.
